Markus Warmuth
President & CEO at Monte Rosa Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Monte Rosa Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Monte Rosa Therapeutics Inc. June 12, 202499.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −9,500 | $23.18 | $220,210 |
| Jun 1, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −4,998 | $19.41 | $97,011 |
| Jun 1, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −468 | $19.73 | $9,234 |
| May 1, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −5,467 | $18.92 | $103,436 |
| Apr 14, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −8,000 | $17.64 | $141,120 |
| Mar 2, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −5,466 | $17.92 | $97,951 |
| Jan 7, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −3,707 | $23.24 | $86,151 |
| Jan 7, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −1,450 | $23.88 | $34,626 |
| Jan 7, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −309 | $24.57 | $7,592 |
| Jan 5, 2026 | Monte Rosa Therapeutics Inc. | Open-market sale | −10,135 | $15.17 | $153,748 |
| Jan 2, 2026 | Monte Rosa Therapeutics Inc. | Grant or award | +90,000 | — | — |
| Jan 2, 2025 | Monte Rosa Therapeutics Inc. | Grant or award | +128,000 | — | — |
Questions about Markus Warmuth
What boards is Markus Warmuth on?
Markus Warmuth sits on the board of Monte Rosa Therapeutics Inc.
What company is Markus Warmuth the CEO of?
Markus Warmuth is President & CEO of Monte Rosa Therapeutics Inc.
How long has Markus Warmuth served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.